LyfeSci Research & Innovation
Research Services • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 5417 |
| Keywords | Pharmacovigilance, Medical Writing, Biostatistics, Clinical Pharmacology, Clinical Data Management, Phase I Studies, Phase Ii Studies, Phase Iii Studies, Pre-Clinical Consulting, Pre-Ind Services, Rwe/Rwd Studies |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at LyfeSci Research & Innovation
Myra Zerr-Korolev
Director of Operations
About LyfeSci Research & Innovation
Personalizing your therapeutic development journey—from inception to approval—using innovative solutions, including the power of AI and beyond.
$
LyfeSci Research & Innovation revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
LyfeSci Research & Innovation has never raised funding before.
France
United Kingdom
Italy
Australia
Germany
Frequently asked questions
LyfeSci Research & Innovation is located in XX.
LyfeSci Research & Innovation was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
LyfeSci Research & Innovation has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
